---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-015604"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T00:44:39.506301+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Agenus proposes 1-for-20 reverse stock split to regain Nasdaq $1 compliance

## Summary
- Reverse stock split at 1:20 ratio proposed to lift share price above $1 Nasdaq minimum.
- Special shareholder meeting set for April 3, 2024 to vote on the split.
- Company plans BLA submission for metastatic colorectal cancer with potential 2025 launch.
- Also exploring monetization of royalty assets and real estate to strengthen finances.
- Engaged in discussions with pharmaceutical companies for potential cash infusions.

## SEC filing metadata
- accession: 0000950170-24-015604
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000095017024015604/0000950170-24-015604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000095017024015604/agen-20240215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-015604
- JSON: https://secwatch.observer/filing/0000950170-24-015604.json
- Plain text: https://secwatch.observer/filing/0000950170-24-015604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.